ANI Pharmaceuticals
ANIP
ANIP
170 hedge funds and large institutions have $499M invested in ANI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 28 closing their positions.
Holders
170
Holders Change
-20
Holders Change %
-10.53%
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
65
Reduced
59
Closed
28
Calls
$3.63M
Puts
$2.6M
Net Calls
+$1.03M
Net Calls Change
+$2.67M
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$22.5M |
| 2 |
2
Arrowstreet Capital
Boston,
Massachusetts
|
$7.92M |
| 3 |
3
Goldman Sachs
New York
|
$17.2M |
| 4 |
QI
4
QS Investors
New York
|
$2.1M |
| 5 |
HRCM
5
Hawk Ridge Capital Management
Los Angeles,
California
|
$11.6M |
